Prelude Therapeutics

• NCT05665530

  Phase 1, Completed, 86 people, 27 Dec 2022

• NCT05107856

  Phase 1, Terminated, 21 people, 4 Nov 2021

• Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis

  Grants or research support, 28 Jan 2019

Sources: pubmed.ncbi.nlm.nih.gov